Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?

類似資料

• Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
  著者:: Yip, Po Yee
  出版事項: (2015)
• Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling
  著者:: Pal, Sumanta K., 等
  出版事項: (2010)
• Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
  著者:: Wanigasooriya, Kasun, 等
  出版事項: (2020)
• Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
  著者:: Elfiky, Aymen A, 等
  出版事項: (2011)
• Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway
  著者:: Wang, Er-Min, 等
  出版事項: (2018)